AI Health Pioneer Valeo raises $12 million in Series B
Summary
This investment will fuel the companys mission to expand its personalized, science-backed healthcare solutions across the KSA, UAE, and the wider GCC region.Co-founded by Sundeep Sahni, Nadine Karadag, and Ankur Majumder, Valeo Health utilizes its proprietary Longevity technology to deliver tailored treatment plans, addressing individual health needs. The funding round, led by Flintera, saw participation from existing investors like Nuwa Capital and FJ Labs, alongside new investors Oraseya and Eirad.This funding enables us to scale our AI technology, enhance our product offerings, and expand our reach, said CEO Sundeep Sahni, emphasizing the companys commitment to proactive healthcare. Nadine Karadag highlighted the investments validation of the teams efforts and its role in scaling personalized healthcare.Investors expressed strong confidence in Valeos vision and execution. Flintera recognized Valeos potential to shape the future of preventive care, while Nuwa Capital praised the companys strong cross-border potential and impressive year-over-year growth.Valeo Healths success in delivering real-time insights and tailored wellness solutions has solidified its position as a trusted name in the regions health-tech sector. This new funding will enable the company to further revolutionize personalized healthcare, making it more accessible to individuals across the GCC.